Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novavax

Novavax’s COVID vaccine gets US nod as latest pandemic weapon

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Tribune News Service

FDA authorizes protein-based Novavax Covid vaccine for adults

Approval of shot widens options against the virus as CDC will meet next week to decide whether to sign off on vaccine

The Guardian - US

Novavax Tanks On New Troubles For Its Newly Authorized Covid Vaccine

The FDA authorized Novavax's Covid vaccine for emergency use, but NVAX stock tumbled on Thursday on warnings facing the two-dose regimen.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

US regulators OK new COVID-19 shot option from Novavax

The U.S. is getting another COVID-19 vaccine choice

The Independent UK

Novavax Covid vaccine becomes fourth to receive FDA approval

The protein-based vaccine still needs to be approved by the CDC before it can start to be administered

The Independent UK

FDA authorizes Novavax COVID vaccine for emergency use

"Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19."

Axios

The Good News For Moderna's Covid Shot Wasn't Good News For Its Stock

Moderna stock fell Tuesday after the company said its omicron-targeting booster generated antibodies capable of tackling new variants.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Will Novavax's Covid Booster Thesis Play Out? What The Survey Says

Novavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The results come as NVAX stock climbs.

Investors Business Daily

Novavax, Moderna, BioNTech Surge To 3-Month High As Omicron Boosters Loom

Vaccine stocks Novavax, Moderna and BioNTech surged to a recent high Friday on growing enthusiasm for an omicron booster campaign in the fall.

Investors Business Daily

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

ABC News

Novavax Gets Expanded Authorization From European Commission For COVID-19 Vaccine

The European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Novavax’s (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for adolescents aged between 12 and 17 years.

Benzinga

The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped

The FDA requested vaccine makers update their Covid shots to include an omicron-fighting element on Thursday, and BNTX stock surged.

Investors Business Daily

COVID vaccination reboot coming this fall to add tweaks for new coronavirus variants

The FDA will have to decide the exact recipe. But expect a combination shot that adds protection against omicron or some of its newer relatives to the original vaccine.

Chicago Sun-Times

Taiwan to receive first doses of Novavax COVID vaccine this week

Taiwan will take delivery of its first doses of the Novavax Inc COVID-19 vaccine this week, received under the COVAX sharing scheme, the government said on Wednesday.

Reuters

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending…

Benzinga

The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Novavax Stock Is Up 11% Today

Novavax Inc (NASDAQ: NVAX) shares are trading higher Thursday after the company announced that its COVID-19 vaccine was recommended for an expanded conditional marketing authorization in the European Union for adolescents aged 12 through 17.

Reuters

COVID-19 vaccine scheme for world's poorest pushes for delivery slowdown

Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers including Pfizer and Moderna to cut or slow deliveries of about half a billion shots so doses are not wasted.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine

Novavax could struggle to find a U.S. market for its Covid shot, according to the latest IBD/TIPP Poll as NVAX stock continues to flounder.

Benzinga

Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its Decision

The Australian regulatory authority has conditionally approved Novavax Inc's (NASDAQ:NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine as a booster in individuals aged 18 and over. The provisional registration was based on data from Novavax's Phase 2 trial conducted in Australia, wherein a single booster dose of Nuvaxovid was administered to healthy adult participants approximately six months after…

Benzinga

5 Biotech Stocks To Watch During The Week Of June 13

Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a compilation of five stocks that should be on your radar in the week of June 13: 1. Novavax

Salon

The hard road for the Novavax vaccine

Novavax now in financial trouble after missing peak vaccinations

Benzinga

Why Moderna Stock Is Moving Lower Today

Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday as vaccine stocks fall in sympathy with Novavax Inc (NASDAQ: NVAX) following reports the FDA's decision on the company's COVID-19 vacci

Investors Business Daily

Novavax Dive Continues As FDA Reviews New Covid Shot Information

Three days after the FDA's advisors recommended Novavax's Covid shot, the agency had yet to make a move, and NVAX stock toppled.

Benzinga

Why Novavax Stock Is Falling Today

Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following reports that the U.S. Food and Drug Administration's decision on the company's COVID-19 vaccine could be delayed to review manufacturing changes.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.